The Low and Exaggerated Effectiveness of Checkpoint Inhibitor Immunotherapies
Executive Summary Checkpoint inhibitors have low effectiveness for their exorbitant costs. These exorbitant costs make them desirable treatments for oncologists and cancer centers. Introduction This article addresses the low general effectiveness of checkpoint inhibitor immunotherapies.